Board of Trustees

C. Douglas Webb, Jr. PhD

Retired
Chair

Carol J. Baker, MD

Baylor College of Medicine

John G. Bartlett, MD

Johns Hopkins Hospital

Emilio A. Emini, PhD

Pfizer Inc.

Jeffrey P. Engel, MD

North Carolina Department of Health and Human Services

Craig R. Engesser

Downingtown, PA

Mark B. Feinberg, MD, PhD

Merck & Co.

John H. Johnson

Lilly Oncology

Tobi Beth Karchmer, MD

BD Diagnostics

Samuel L. Katz, MD, DSc

Duke University Medical Center

William J. Ledger, MD

New York -- Presbyterian Hospital, Weill Medical College of Cornell University

Edward B. Lewin, MD

Bethesda, MD

G. Lynn Marks, MD

GlaxoSmithKline, Inc.

William J. Martone, MD

MedImmune, Inc.

Sherri Michelstein

Alembic Health Communications

Kay Mitzel

Sausilto, CA

George A. Pankey, MD

Oschner Clinic Foundation

Kevin M. Rooney

Beacon Consulting Group

Vijay Samant

Vical, Inc.

Eric Schultz

Quantia Communications, Inc.

Leon G. Smith, MD, MACP

University of Medicine and Dentistry of New Jersey

Edmund C. Tramont, MD

National Institutes of Health

Executive Director

Len Novick


Modified December 2011